Cargando…

Comparison of drug abuse in Germany and China

Drug abuse has a long, but also different history in Germany and China. The Opium War largely influenced the history of China in 19th century; however, China was once recognized as a drug-free nation for 3 decades from the 1950s to the 1980s. Drug abuse has spread quickly since re-emerging as a nati...

Descripción completa

Detalles Bibliográficos
Autores principales: Michels, Ingo Ilja, Fang, Yu-xia, Zhao, Dong, Zhao, Li-yan, Lu, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091797/
https://www.ncbi.nlm.nih.gov/pubmed/17883935
http://dx.doi.org/10.1111/j.1745-7254.2007.00633.x
_version_ 1783510062949466112
author Michels, Ingo Ilja
Fang, Yu-xia
Zhao, Dong
Zhao, Li-yan
Lu, Lin
author_facet Michels, Ingo Ilja
Fang, Yu-xia
Zhao, Dong
Zhao, Li-yan
Lu, Lin
author_sort Michels, Ingo Ilja
collection PubMed
description Drug abuse has a long, but also different history in Germany and China. The Opium War largely influenced the history of China in 19th century; however, China was once recognized as a drug-free nation for 3 decades from the 1950s to the 1980s. Drug abuse has spread quickly since re-emerging as a national problem in China in the late 1980s. The number of registered drug abusers increased from 70 000 in 1990 to more than 1 million by the end of 2005. In past decades, illicit drug trafficking and production have swept most provinces in China, and drug abuse has caused many problems for both abusers and the community. One major drug-related problem is the spread of HIV, which has caused major social and economic damage in China. Germany, the largest developed European country, also faces the drug and addiction problem. Germany has about 150 000 heroin addicts, for whom HIV/AIDS has become a serious threat since the mid 1980s. To control the drug problem, the German Government adopted the “Action Plan on Drugs and Addiction” in 2003; the China Central Government approved a similar regulation in the antidrug campaign in 2005. Germany has experience in reducing drug-related harm. The methadone maintenance treatment (MMT) program has run for more than 20 years and the public has become more tolerant of addicts. In 2003, China began the MMT program for controlling the spread of HIV/AIDS. It is necessary for China to learn from developed countries to acquire success in its antidrug campaign. In this review, we will go over the differences and similarities in drug abuse between Germany and China. The differences are related to history, population and economics, drug policy context, drug laws, HIV/hepatitis C virus infection, the MMT program and so on. These 2 nations have drug abuse problems with different histories and currently use different approaches to handle illicit drug marketing and use. The legal penalties for illicit drug offences reflect the social differences of these 2 nations with respect to the seriousness of particular types of crimes. The characteristics of the MMT program may also influence patterns of drug abuse in these 2 nations and China should improve the MMT program based on the successful model in Europe, the USA, and Australia. We recommend more dialogue and collaboration between Germany and China.
format Online
Article
Text
id pubmed-7091797
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-70917972020-03-24 Comparison of drug abuse in Germany and China Michels, Ingo Ilja Fang, Yu-xia Zhao, Dong Zhao, Li-yan Lu, Lin Acta Pharmacol Sin Article Drug abuse has a long, but also different history in Germany and China. The Opium War largely influenced the history of China in 19th century; however, China was once recognized as a drug-free nation for 3 decades from the 1950s to the 1980s. Drug abuse has spread quickly since re-emerging as a national problem in China in the late 1980s. The number of registered drug abusers increased from 70 000 in 1990 to more than 1 million by the end of 2005. In past decades, illicit drug trafficking and production have swept most provinces in China, and drug abuse has caused many problems for both abusers and the community. One major drug-related problem is the spread of HIV, which has caused major social and economic damage in China. Germany, the largest developed European country, also faces the drug and addiction problem. Germany has about 150 000 heroin addicts, for whom HIV/AIDS has become a serious threat since the mid 1980s. To control the drug problem, the German Government adopted the “Action Plan on Drugs and Addiction” in 2003; the China Central Government approved a similar regulation in the antidrug campaign in 2005. Germany has experience in reducing drug-related harm. The methadone maintenance treatment (MMT) program has run for more than 20 years and the public has become more tolerant of addicts. In 2003, China began the MMT program for controlling the spread of HIV/AIDS. It is necessary for China to learn from developed countries to acquire success in its antidrug campaign. In this review, we will go over the differences and similarities in drug abuse between Germany and China. The differences are related to history, population and economics, drug policy context, drug laws, HIV/hepatitis C virus infection, the MMT program and so on. These 2 nations have drug abuse problems with different histories and currently use different approaches to handle illicit drug marketing and use. The legal penalties for illicit drug offences reflect the social differences of these 2 nations with respect to the seriousness of particular types of crimes. The characteristics of the MMT program may also influence patterns of drug abuse in these 2 nations and China should improve the MMT program based on the successful model in Europe, the USA, and Australia. We recommend more dialogue and collaboration between Germany and China. Nature Publishing Group UK 2007-10 /pmc/articles/PMC7091797/ /pubmed/17883935 http://dx.doi.org/10.1111/j.1745-7254.2007.00633.x Text en © CPS and SIMM 2007 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Michels, Ingo Ilja
Fang, Yu-xia
Zhao, Dong
Zhao, Li-yan
Lu, Lin
Comparison of drug abuse in Germany and China
title Comparison of drug abuse in Germany and China
title_full Comparison of drug abuse in Germany and China
title_fullStr Comparison of drug abuse in Germany and China
title_full_unstemmed Comparison of drug abuse in Germany and China
title_short Comparison of drug abuse in Germany and China
title_sort comparison of drug abuse in germany and china
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091797/
https://www.ncbi.nlm.nih.gov/pubmed/17883935
http://dx.doi.org/10.1111/j.1745-7254.2007.00633.x
work_keys_str_mv AT michelsingoilja comparisonofdrugabuseingermanyandchina
AT fangyuxia comparisonofdrugabuseingermanyandchina
AT zhaodong comparisonofdrugabuseingermanyandchina
AT zhaoliyan comparisonofdrugabuseingermanyandchina
AT lulin comparisonofdrugabuseingermanyandchina